Compound Detail
CHEMBL1106
EPINASTINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1106 |
| Name | EPINASTINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | WHWZLSFABNNENI-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
5
Targets
8
Activities
2
Assay Types
0
PK Parameters
20
Publications
4
Known Names
5
Indications
Molecular Properties
249.3
MW (Da)
2.47
ALogP
3
HBA
1
HBD
41.6
PSA (Ų)
0.78
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2003 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Eye Manifestations Hypersensitivity Rhinitis, Allergic, Perennial Rhinitis, Allergic, Seasonal Rhinitis, Allergic, Seasonal
ATC Classification
R06AX24
epinastine
Level 1: RESPIRATORY SYSTEM
Level 2: ANTIHISTAMINES FOR SYSTEMIC USE
S01GX10
epinastine
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
Activity Summary
IC50 7 meas. best 8.8
Ki 1 meas. best 8.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histamine H1 receptor CHEMBL3943 | Ki | 8.85 | 8.85 | 1.4 | 1 |
| Histamine H1 receptor CHEMBL3943 | IC50 | 8.8 | 8.8 | 1.6 | 1 |
| Multidrug and toxin extrusion protein 1 CHEMBL1743126 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL1743122 | IC50 | 5.37 | 5.37 | 4300.0 | 1 |
| Multidrug and toxin extrusion protein 2 CHEMBL1743127 | IC50 | 4.53 | 4.53 | 29800.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.04 | 4.0133 | 91201.1 | 3 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 24088053 | 10.1021/jm400813y | D(2) dopamine receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 24088053 | 10.1021/jm400813y | D(1A) dopamine receptor | 2 |
| 7650688 | 10.1021/jm00017a019 | Histamine H1 receptor | 2 |
| 23241029 | 10.1021/jm301302s | Multidrug and toxin extrusion protein 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
| 23241029 | 10.1021/jm301302s | Multidrug and toxin extrusion protein 2 | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| 18448342 | 10.1016/j.bmc.2008.04.028 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 15911273 | 10.1016/j.bmcl.2005.03.080 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 1 |
| 15857133 | 10.1021/jm048980b | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine